There are 700 resources available
520P - Guidelines for time-to-event endpoints in gastrointestinal cancer using real-world data
Presenter: Pauline Vissers
Session: Poster Display session
521P - Risk factors for early discontinuation of anamorelin hydrochloride in patients with cancer cachexia: A multicenter, retrospective cohort study (HGCSG2201)
Presenter: Kazuaki Harada
Session: Poster Display session
522P - Intra-arterial hepatic chemotherapy: Role beyond colorectal cancer?
Presenter: Elsa El Rawadi
Session: Poster Display session
523P - Investigation and analysis of nutritional risks on oral nutrition supplementation during the peri-radiotherapy period in patients in Shandong province, China: A multicenter cross-sectional study
Presenter: Cong Wang
Session: Poster Display session
525P - Prevalence of UGT1A1*28 promoter polymorphism in the omani population: Implications for irinotecan treatment in GI cancer
Presenter: AHMAD ALGHOCHE
Session: Poster Display session
526P - DPYD polymorphisms in patients with gastrointestinal cancers: Prevalence and impact on fluoropyrimidine tolerability- An Italian single institution experience
Presenter: Chiara Carlomagno
Session: Poster Display session
527P - Systematic detection of dihydropyrimidine dehydrogenase (DPD) deficiency using UH2/U ratio in patients with digestive cancers in central Tunisia: Toxicity profile
Presenter: Maissa Mahjoub
Session: Poster Display session
528P - Comparison of endoscopic ultrasound-guided tissue acquisition for solid liver masses: Menghini needle with a lateral reverse bevel vs. Franseen needle
Presenter: Jae Hee CHO
Session: Poster Display session
529P - Development and validation of a high-throughput drug screen (HTDS) from patient-derived tumor organoids (PDTO) from gastrointestinal malignancies: Clinical and genomic correlations
Presenter: Uqba Khan
Session: Poster Display session
530P - BUD31 drives carcinogenesis by up-regulating MCM7 through intronic splicing
Presenter: Liu Hongjin
Session: Poster Display session